houston tirzepatide weight loss protocol for before and after: realistic results, timelines, and what to expect The Weight Loss Shot – Tirzepatide in Houston: Weight Loss

Suicidal Ideation and Other Rare Undesirable Effects With the expanding role in diabetes and obesity, as well as potential extending therapeutic uses in the neurological area (e.g., stroke, neurodegenerative disorders, alcohol- and substance-use disorders), rare side effects have recently emerged

Contemporary OB-GYN: FDA approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive Safety Labeling Update for Nexplanon Patient Experiences with Nexplanon Summary of MedWatch Voluntary Reports for Nexplanon (240 reports of device complications for 1,577 reports submitted voluntarily, mainly by consumers) Rare Disease: FDA Approves First Treatment for Children With Menkes Disease The FDA approved the first-ever treatment for Menkes disease: Zydus Life Sciences Zycubo (copper histidinate) daily subcutaneous injection for pediatric patients

It is a long-acting amylin analog, a completely different mechanism from the GLP-1 receptor agonists that dominate the conversation right now

Every Direct Meds patient is paired with a dedicated licensed nurse who stays with you for the full duration of treatment

The takeaway: GLP-1s are just one cost driver the real focus for HR is helping employees manage healthcare spending with the tools available